Individualized toxicity‐titrated 6‐mercaptopurine increments during high‐dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia: A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study

Thomas L. Frandsen, Jonas Abrahamsson, Birgitte Lausen, Kim Vettenranta, Mats Heyman, Michael Behrentz, Anders Castor, Peder S. Wehner, Britt‐marie Frost, Elisabeth Wreford Andersen, Kjeld Schmiegelow

Research output: Contribution to journalJournal articleResearchpeer-review

Fingerprint

Dive into the research topics of 'Individualized toxicity‐titrated 6‐mercaptopurine increments during high‐dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia: A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study'. Together they form a unique fingerprint.

Medicine & Life Sciences